Reading Guide
Introduction
Methods and processes
Consumer-centred care in the context of COVID-19
Definition of disease severity
Definition of disease severity for adults
Pulse oximeters
Pulse oximeters for adults
Pulse oximeters for children and adolescents
Drug treatments
Recommended drug treatments
Casirivimab plus imdevimab (Ronapreve)
Casirivimab plus imdevimab (Ronapreve) for adults
Casirivimab plus imdevimab (Ronapreve) for pregnant or breastfeeding women
Casirivimab plus imdevimab (Ronapreve) for children and adolescents
Corticosteroids (inhaled)
Corticosteroids (inhaled) for adults
Corticosteroids (inhaled) for children and adolescents
Corticosteroids (systemic)
Corticosteroids (systemic) for adults
Corticosteroids (systemic) for pregnant or breastfeeding women
Corticosteroids (systemic) for children and adolescents
Molnupiravir (Lagevrio)
Molnupiravir (Lagevrio) for adults
Molnupiravir (Lagevrio) for pregnant or breastfeeding women
Molnupiravir (Lagevrio) for children and adolescents
Nirmatrelvir plus ritonavir (Paxlovid)
Nirmatrelvir plus ritonavir (Paxlovid) for adults
Nirmatrelvir plus ritonavir (Paxlovid) for pregnant or breastfeeding women
Nirmatrelvir plus ritonavir (Paxlovid) for children and adolescents
Abatacept
Abatacept for adults
Baricitinib for children and adolescents
Infliximab
Infliximab for adults
Sarilumab for adults
Sarilumab for children and adolescents
Tocilizumab for children and adolescents
Regdanvimab (Regkirona)
Regdanvimab (Regkirona) for adults
Regdanvimab (Regkirona) for pregnant or breastfeeding women
Regdanvimab (Regkirona) for children and adolescents
Remdesivir (Veklury)
Remdesivir (Veklury) for adults
Remdesivir (Veklury) for pregnant or breastfeeding women
Remdesivir (Veklury) for children and adolescents
Sotrovimab (Xevudy)
Sotrovimab (Xevudy) for adults
Sotrovimab (Xevudy) for pregnant women
Sotrovimab (Xevudy) for children and adolescents
Tixagevimab plus cilgavimab (Evusheld)
Tixagevimab plus cilgavimab (Evusheld) for adults
Tixagevimab plus cilgavimab (Evusheld) for pregnant or breastfeeding women
Tixagevimab plus cilgavimab (Evusheld) for children and adolescents
Drug treatments that are not recommended
Favipiravir
Interferon beta-1a
Interferon beta-1a plus lopinavir-ritonavir
Ivermectin
Lopinavir-ritonavir
Drug treatments not recommended outside of clinical trials
Other drug treatments
Drug treatments under review
Drug treatments not currently under review
Casirivimab plus imdevimab (Ronapreve) for post-exposure prophylaxis
Tixagevimab plus cilgavimab (Evusheld) for pre-exposure prophylaxis
Tixagevimab plus cilgavimab (Evusheld) for post-exposure prophylaxis
Respiratory management
Respiratory management of the deteriorating patient
Prone positioning for adults
Prone positioning and CPR
VTE prophylaxis for pregnant and postpartum women
VTE prophylaxis for children and adolescents
Therapies for existing indications in patients with COVID-19
Oestrogen-containing therapies
Care after COVID-19
Goals of care
Assessment and diagnosis in patients with continuing symptoms after COVID-19
Management in patients with continuing symptoms after COVID-19
Timing of surgery following COVID-19 infection
Antenatal corticosteroids
Magnesium sulfate
Paediatric Inflammatory Multisystem Syndrome (PIMS-TS)
Immunomodulatory agents
VTE prophylaxis
Abbreviations and Acronyms
